Directive 2001/83/EC of the European Parliament and of the… Article 24
Article 24
Authorization shall be valid for five years and shall be renewable for five-year periods, on application by the holder at least three months before the expiry date and after consideration by the competent authority of a dossier containing in particular details of the data on pharmacovigilance and other information relevant to the monitoring of the medicinal product.
Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04
CitationArticle 24 of Directive 2001/83/EC of the European Parliament and of the… (LawPlayer, data as of 2026-07-04)